Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Salivary Gland Neoplasms 1Rectal Neoplasms 1Oligodendroglioma 1Neurotoxicity Syndromes 1Neoplasms 1Metastatic Malignant Female Reproductive System Neoplasm 1Lung Neoplasms 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Central Nervous System Neoplasms 1Breast Carcinoma In Situ 1Brain Neoplasms 1Astrocytoma 1Anatomic Stage II Breast Cancer AJCC v8 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

pembrolizumab 25Cyclophosphamide 20Nivolumab 13Doxorubicin 13Carboplatin 10Surveys and Questionnaires 9Paclitaxel 9Exercise 9atezolizumab 8Vincristine 8Rituximab 8Radiotherapy 8Prednisone 8Dexamethasone 8Bevacizumab 8venetoclax 7fludarabine 7Pemetrexed 7Fluorouracil 7Docetaxel 7Blood Specimen Collection 7lenvatinib 6dostarlimab 6cemiplimab 6budigalimab 6Oxaliplatin 6Cisplatin 6durvalumab 5Leucovorin 5Lenalidomide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Neoplasms × Radiotherapy, Conformal × Clear all
NCT02276885 2025-12-30

Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial

NYU Langone Health

Phase NA Active not recruiting
284 enrolled 10 charts
Breast

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡